These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8703804)

  • 1. Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis.
    Bergamaschi G; Perfetti V; Tonon L; Novella A; Lucotti C; Danova M; Glennie MJ; Merlini G; Cazzola M
    Br J Haematol; 1996 Jun; 93(4):789-94. PubMed ID: 8703804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies.
    Bolognesi A; Tazzari PL; Olivieri F; Polito L; Lemoli R; Terenzi A; Pasqualucci L; Falini B; Stirpe F
    Br J Haematol; 1998 Apr; 101(1):179-88. PubMed ID: 9576199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line.
    Flavell DJ; Cooper S; Okayama K; Emery L; Flavell SU
    Hematol Oncol; 1995; 13(4):185-200. PubMed ID: 7557895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing.
    Bonardi MA; French RR; Amlot P; Gromo G; Modena D; Glennie MJ
    Cancer Res; 1993 Jul; 53(13):3015-21. PubMed ID: 7686448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluation.
    Tazzari PL; Bolognesi A; De Totero D; Lemoli RM; Fortuna A; Conte R; Crumpton MJ; Stirpe F
    Br J Haematol; 1994 Jan; 86(1):97-105. PubMed ID: 7912101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
    Flavell DJ; Flavell SU; Boehm DA; Emery L; Noss A; Ling NR; Richardson PR; Hardie D; Wright DH
    Br J Cancer; 1995 Dec; 72(6):1373-9. PubMed ID: 8519647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells.
    Bregni M; Siena S; Formosa A; Lappi DA; Martineau D; Malavasi F; Dorken B; Bonadonna G; Gianni AM
    Blood; 1989 Feb; 73(3):753-62. PubMed ID: 2465042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine.
    Polito L; Bolognesi A; Tazzari PL; Farini V; Lubelli C; Zinzani PL; Ricci F; Stirpe F
    Leukemia; 2004 Jul; 18(7):1215-22. PubMed ID: 15103391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell-associated antigens: effects on target cells and on normal myeloid precursors (CFU-GM).
    Barbieri L; Dinota A; Gobbi M; Tazzari PL; Rizzi S; Bontadini A; Lemoli RM; Tura S; Stirpe F
    Eur J Haematol; 1989 Mar; 42(3):238-45. PubMed ID: 2784390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and performance of a bispecific F (ab'gamma)2 antibody for delivering saporin to a CD7+ human acute T-cell leukaemia cell line.
    Flavell DJ; Cooper S; Morland B; Flavell SU
    Br J Cancer; 1991 Aug; 64(2):274-80. PubMed ID: 1716453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.
    Flavell DJ; Boehm DA; Noss A; Flavell SU
    Br J Cancer; 1997; 75(7):1035-43. PubMed ID: 9083340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies.
    French RR; Penney CA; Browning AC; Stirpe F; George AJ; Glennie MJ
    Br J Cancer; 1995 May; 71(5):986-94. PubMed ID: 7734325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluation.
    Tazzari PL; Zhang S; Chen Q; Sforzini S; Bolognesi A; Stirpe F; Xie H; Moretta A; Ferrini S
    Br J Cancer; 1993 Jun; 67(6):1248-53. PubMed ID: 8512810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective lesions of rabbit extraocular muscles injected with the anti-AChR immunotoxin saporin-mAb 73.
    Campos EC; Schiavi C; Bolognesi A; Bellusci C; Lubelli C; Duca A; Polito L; Poulas K; Tzartos SJ; Stirpe F
    Curr Eye Res; 2002 Jan; 24(1):58-65. PubMed ID: 12187496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective killing of CD4+ and CD8+ cells with immunotoxins containing saporin.
    Barbieri L; Bolognesi A; Dinota A; Lappi DA; Soria M; Tazzari PL; Stirpe F
    Scand J Immunol; 1989 Sep; 30(3):369-72. PubMed ID: 2571186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates.
    Siena S; Lappi DA; Bregni M; Formosa A; Villa S; Soria M; Bonadonna G; Gianni AM
    Blood; 1988 Aug; 72(2):756-65. PubMed ID: 3042047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytotoxic activity of ribosome-inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities.
    Bagga S; Seth D; Batra JK
    J Biol Chem; 2003 Feb; 278(7):4813-20. PubMed ID: 12466280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cytotoxic activity of saporin anti-gp185/HER-2 immunotoxins.
    Tecce R; Digiesi G; Savarese A; Trizio D; Natali PG
    Int J Cancer; 1993 Aug; 55(1):122-7. PubMed ID: 8102128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturation.
    Gosselaar PH; van-Dijk AJ; de-Gast GC; Polito L; Bolognesi A; Vooijs WC; Verheul AF; Krouwer HG; Marx JJ
    Eur J Clin Invest; 2002 Mar; 32 Suppl 1():61-9. PubMed ID: 11886434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.